EXHIBIT 6


                         STATEMENT OF ARTHUR C. SPINNER
                                       AT
         MAY 22, 2003 STOCKHOLDERS MEETING OF TRIKON TECHNOLOGIES, INC.

     My name is Art Spinner, the managing member of Spinner Asset Management,
LLC, the investment advisor of Spinner Global Technology Fund, Ltd. The Fund is
the largest single stockholder of Trikon. The Fund's investment totals over 1.5
million shares. Chris Dobson, the Company's current Chairman, currently owns
1.235 million shares, having sold 460,000 shares last week on the first day he
could legally do so.

     We invested in Trikon based on the belief that it had leading edge
technology which could gain traction in the marketplace, if the Company could
grow beyond its European roots. Barring that, we have always felt, and have made
clear to the management on numerous occasions, that the technology would be
worth more in the hands of a larger company with more credibility in the
customer base.

     In the spring of 2001, the Company needed additional working capital to
support its business. Our Fund made a $10 million investment at that time, in
fresh capital, through a private placement, partly in consideration of an
understanding that the Fund could recommend a director with significant industry
experience to work with the Company to expand its horizons.

     Since that time, we have recommended to the Company a number of leading
figures in the semiconductor industry as potential directors. Virtually all of
these candidates are or have been CEOs of public technology companies, and have
considerable credibility both with the customer community in the US, Asia and
Europe and with the investment community as well. These are qualities which in
our view the Company and its shareholders would greatly benefit from.

     From April 30, 1998 to April 30, 2003, Trikon share price has declined by
64%. Our view is that at some point not only the management responsible for this
result, but the Board supervising it, have to be held accountable. Our opinion
is that any of the persons we have recommended over the past 2 years, all of
whom have been rejected by the Company as "unqualified," would have woken the
Board and management team from their slumber by asking the right questions and
demanding the right answers.

     Just two weeks ago, two of my colleagues met with Dr. Kiwan in London, to
see if an amicable resolution could be reached. Dr. Kiwan informed us that the
Board was then discussing increasing the number of directors to eight after the
annual stockholders meeting and putting on two additional members, whom he was
personally recommending; one of these was Dr. Juergen Knorr who visited the
Company the same day as our meeting in London. Dr. Kiwan suggested that one way
to alleviate our concerns would be increasing the Board to nine, and adding our
recommended candidate as the third additional director. We clearly stated to Dr.
Kiwan that we believed the Board had a fiduciary duty when electing directors at
the annual meeting to let those stockholders know about any plans to increase





the size of the board, and the candidates being considered. Our view was that
this should be disclosed, and a revised proxy be prepared by the Company, even
if it meant temporarily delaying the upcoming shareholders meeting. The Board
rejected Dr. Kiwan's proposed resolution and rejected our recommendation.

     The Company has expressed concern about a nine man board being unwieldy. We
are inclined to agree and suggest the concern be resolved by Dr. Dobson and Mr.
Wertheimer's resignations. We would also call your attention to Institutional
Shareholder Services's (ISS), the leading corporate governance advisory service,
view that independent directors in a public company have little value, unless
they are in the majority. In addition, proposed Nasdaq corporate governance
rules will require the majority of the directors to be independent.

     After spending the last two years watching the Company's revenues, earnings
and stock price fall, and frustrated with the Board's continual rejection of the
Fund's recommendations for directors, the Fund decided some stockholder had to
come forward to contest the Board for the benefit of all stockholders.

     We are proposing Peter Simone and William Elder to serve in the place of
Christopher Dobson and Stephen Wertheimer. In 1981, Bill Elder was a founder of
Genus Inc., and is now serving as its Chairman, President and CEO. While Trikon
management contends that Dr. Elder is affiliated with a competitor, neither
Trikon nor Genus list one another as competitors in their respective 10K filings
with the SEC. Peter Simone has served in a variety of senior management
positions with several successful semiconductor and semiconductor equipment
companies since 1973. He is currently an independent director of three
successful public companies: Cymer Inc., Newport Corporation and Oak Technology
Inc. Over his 30 year career in the semiconductor industry he has developed
numerous customer and investor relationships and has been a money maker for his
investors and a trusted supplier for his customers. Both candidates are deeply
experienced in the semiconductor industry. They are fully aware of their
responsibilities as independent directors and look forward to the challenge of
helping to make Trikon successful.

     Last Friday, Trikon brought a legal proceeding against the Fund and me
personally, in which it made many unfounded and incorrect allegations. One
allegation was that our motivation in recommending an independent director is to
get inside information in order to trade in Trikon shares. In point of fact,
over the last two years other than the Trikon private placements, the Fund has
neither bought nor sold any Trikon stock.

     By contrast, only one week ago, Trikon Chairman Christopher Dobson sold
460,000 shares of stock for $2.70, 10 cents above the 3+ year lows. This was
done at a time when the Company has had poor operating results, and using its
cash resources engaging in a fight with its largest shareholder over issues of
corporate governance. One of these issues is compensation.

     Chris Dobson has done very well as an individual during his last six years
at Trikon. Unfortunately virtually all of the $40 mil+ which he has, received
from the company has been in the form of cash compensation rather than share
appreciation. $35 mil from an acquisition transaction, $8.5 mil in so-called
"negotiation fees", a British usage, we call them investment banking fees, in
addition to his salary and bonuses. Dobson's ability to act on the shareholders
behalf has been compromised in our view by his commission agreement with the


                                       2



Company, whereby he would receive an additional fee of up to 3% if and only if
the Company gets sold for over $300 mil.

     Although we congratulate Dr. Dobson on his recently awarded PhD from the
Univerity of Cambridge, we note that the three years of hard work at the
University, from October 1998 to September 2001, coincided with his employment
as Chairman of Trikon and note that in 2000 he received approximately $600,000
in compensation and $1.6 mil in 2001.

     In the preface to his doctoral dissertation, Dr. Dobson thanks Trikon for
its financial and technical support. We would have been happy as shareholders to
know that we were subsidizing his academic ambitions and helping to put some of
the Company's proprietary technology into the public domain.

     The Company has made much of the importance of semiconductor industry
experience for members of its Board of Directors.

     The Company's press release yesterday said that it was looking for someone
with semiconductor industry device experience and strong ties in Asia. Mr.
Wertheimer has neither. Furthermore, his conduct as a director of Spectrumedix
has been criticized by the Delaware Chancery Court in an action by the CEO of
that company against Wertheimer and other directors arising from a board meeting
held in this room. Wertheimer had attacked the CEO of Spectrumedix for working
from home and only going to that company three or four days a week. It does not
seem to us that he has held Chris Dobson to the same standard.

     ISS has independently recommended that Trikon stockholders withhold their
vote for Mr. Wertheimer. A recommendation we agree with.

     We are also concerned with management's proposal to approve the Omnibus
Incentive Plan. The plan would cover 7.8% of the outstanding shares, an
uncommonly large amount. Stock plans should be used to incentivize the
employees, and not just be a perk for senior management and the Board. Our
opposition to the Plan is also based on the failure of the Board to explain in
specific terms what criteria will be used for the grant of awards and what class
of persons will receive the awards. ISS has also recommended that Trikon
stockholders reject the Incentive Plan.

     We had hoped to avoid a proxy contest, spending a good deal of time trying
to reach a constructive response from the board to our recommendations. We
reluctantly concluded that a proxy contest would be the only way to call
shareholder attention to the board's refusals. Therefore, we began this proxy
contest extremely late, but nevertheless have received substantial support.
However, we do not intend to go away. We have a lot of time, effort and money
invested in the Company. Regardless of today's vote, we will continue to watch
over the actions of the Board to ensure that they act properly on behalf of all
shareholders.

     I urge all Trikon shareholders to vote FOR our nominees and AGAINST the
Omnibus Incentive Plan.

     Thank you for your consideration and time.


                                       3